Effect of Digital Follow-up Supported Patient Education on Immunosuppressive Medication Adherence and Quality of Life After Liver Transplantation | NCT07728604

NCT07728604

Overview

NCT ID: NCT07728604
Lead Sponsor: Cansu YıldızOTHER
Official Title: Effect of Digital Follow-up Supported Patient Education on Immunosuppressive Medication Adherence and Quality of Life in Liver Transplant Recipients: A Single-Blind Randomized Controlled Trial.
Brief Summary: This randomized controlled study aimed to evaluate the effect of digital follow-up supported patient education on immunosuppressive medication adherence and quality of life in adult liver transplant recipients. Participants in both groups received standard discharge education. The intervention group additionally received structured digital follow-up messages for 12 weeks, while the control group received standard care only. Medication adherence and quality of life were assessed before and after the intervention using validated questionnaires.
Conditions: Liver Transplantation
Medication Adherence

Status and Timeline

Status: Completed
Last Update Posted: Jul 27, 2026Actual
Start Date: Jan 23, 2026Actual
Primary Completion Date: Jun 20, 2026Actual
Completion Date

Participation Criteria

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Age 18 years or older.

Having undergone liver transplantation.

Currently receiving immunosuppressive therapy after liver transplantation.

Ability to read and write in Turkish.

Ability to use a smartphone to receive and follow digital messages.

Willingness to participate voluntarily in the study.

Provision of written informed consent.

Exclusion Criteria:

Experiencing an acute rejection episode during the study period.

Presence of cognitive, psychiatric, or communication problems that would interfere with participation in the study.

Inability to regularly follow digital messages.

Difficulty reading and understanding Turkish.

Inability to maintain communication throughout the study period.

Refusal to participate in the study.

Study Plan

Study Type: Interventional
Phase: Not Applicable
Enrollment: 48Actual
Primary Purpose: Treatment
Allocation: Randomized
Interventional Model: Parallel Assignment
Masking: Single

Contacts and Locations

Central Contacts: No data available
Locations: Acibadem İzmir Kent Hospital

Similar Studies

Participant Group/Arms

Digital Education GroupExperimental

Participants received standard discharge education plus structured digital follow-up messages for 12 weeks to improve immunosuppressive medication adherence and quality of life.

Behavioral: Digital Follow-up Supported Patient Education

Control GroupActive Comparator

articipants received standard discharge education and routine follow-up care without additional digital follow-up messages.

Other: Standard Care